Document is current
Any future updates will be listed below
-
Authors
Bohrer, Laura R.
Wiley, Luke A.
Wright, Allison T.
Hittle, Bradley
Lang, Mallory J.
Affatigato, Louisa M.
Powell, Kimerly A.
Haefeli, Lorena M.
Han, Ian C.
Mullins, Robert F.
Stone, Edwin M.
Tucker, Budd A. https://orcid.org/0000-0003-2178-1742
-
Funding
Funding for this research was provided by:
National Eye Institute (EY033331)
National Eye Institute (EY036143)
National Science Foundation (2225488)
- License Information
-
More Information
Article History
Received: 15 April 2025
Accepted: 20 October 2025
First Online: 17 November 2025
Declarations
:
: This study was approved by the Institutional Review Board of the University of Iowa (Molecular Genetic Approaches to Inherited Eye Diseases; Approval #200202022; 10/21/2022) and adhered to the tenets set forth in the Declaration of Helsinki, with patients providing written, informed consent. All rat experiments were conducted with the approval of the University of Iowa Animal Care and Use Committee (Stem Cell and Gene Based Treatment of Retinal Degenerative Disease; Animal welfare assurance #1031317; 3/25/2021) and were consistent with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research.
: Not applicable.
: KAP is a paid consultant and shareholder in Cell X Technologies Inc.
